Page last updated: 2024-08-21

medroxyprogesterone and Epithelial Ovarian Cancer

medroxyprogesterone has been researched along with Epithelial Ovarian Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, Y; Liao, H; Sun, Y; Wang, Q; Yi, X; Zhang, Z; Zhou, Q1

Other Studies

1 other study(ies) available for medroxyprogesterone and Epithelial Ovarian Cancer

ArticleYear
NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones.
    Oncology reports, 2012, Volume: 27, Issue:6

    Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cystadenoma; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins; Humans; Luteinizing Hormone; Medroxyprogesterone; Middle Aged; Neoplasms, Glandular and Epithelial; NF-E2-Related Factor 2; Ovarian Neoplasms; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Young Adult

2012